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Tuberculosis (TB) is the leading cause of death worldwide due to an infectious agent. Data have accumulated over decades
suggesting that variability in human susceptibility to TB disease has a genetic component. Toll-like receptors (TLRs) play a
critical role in initiating the innate immune response to many pathogens in mouse models, but little is known about their role
in human infections. Human TLRs have been reported to recognize mycobacterial antigens and initiate an immune response.
We tested the hypothesis that amino acid-altering polymorphisms in five TLRs were associated with susceptibility to TB disease
using a population-based case-control study with 1,312 adult TB patients and controls. Full-coding region sequencing of the
five TLR genes in all 1,312 subjects yielded a data set in excess of 16 Mb. Rare nonsynonymous polymorphisms in TLR6-TLR1-
TLR10 were significantly overrepresented among African-American TB cases compared with ethnically-matched control
subjects. Common nonsynonymous polymorphisms in TLR6-TLR1-TLR10 also were significantly associated with TB disease in
certain ethnic groups. Among African Americans, homozygotes for the common-variant haplotype TLR1-248S, TLR1-602I, and
TLR6-249S had a significantly increased TB disease risk. A transmission/disequilibrium test on an independent sample found
that the TLR1-248S variant was preferentially transmitted to diseased children, thereby confirming disease association. These
results are consistent with recent reports implicating TLR1 variants, including TLR1-602, in significantly altered innate immune
responses. Also consistent with disease association, rare TLR6 variants were defective in their ability to mediate NF-kB signal
transduction in transfected human cells. Taken together, the data suggest that variant TLRs contribute to human susceptibility
to TB disease. Extensive full-exon resequencing was critical for revealing new information about the role of TLRs in human-
pathogen interactions and the genetic basis of innate immune function.
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Susceptibility to Tuberculosis Disease. PLoS ONE 2(12): e1318. doi:10.1371/journal.pone.0001318
INTRODUCTION
Tuberculosis (TB), an infectious disease caused by Mycobacterium
tuberculosis (MTB), is a leading public health problem in the United
States and throughout the world [1]. Development of active TB
disease depends on a complex relationship between the bacterium
and the host. Importantly, only about 10% of presumed
immunologically normal individuals who are exposed to MTB
will develop disease in their lifetime. The molecular mechanisms
responsible for susceptibility to clinical disease caused by this
pathogen are poorly understood.
Many lines of evidence suggest that host genetics contributes to
the susceptibility of humans to developing disease after exposure to
MTB [2–6]. Familial occurrence, and higher rates of TB disease
concordance among monozygotic than dizygotic twins, have been
reported [2,3]. In addition, studies have identified associations
between polymorphisms in several candidate genes and clinical TB
[4–14].Forexample,allelesofgenesencoding HLAclassIIantigens,
mannose-binding protein, natural resistance-associated macrophage
protein 1 (NRAMP1), vitamin D-receptor, interleukin-1 (IL-1), IL-1
receptor, IL-8, IL-12 receptor, MCP-1, DC-SIGN, SP110, TIRAP,
MAL, and interferon-c have been reported to be associated with TB
disease in some populations [4–14]. However, with few exceptions,
the disease-associated alleles reported in these studies have only
relatively modest effects, suggesting that additional susceptibility
genes remain to be discovered.
Toll-like receptors (TLRs) are a family of proteins that play a
key role in the innate immune response to infectious agents
through their ability to discriminate conserved microbial struc-
tures, known as pathogen-associated molecular patterns (PAMPs),
from self [15]. TLR recognition of PAMPs such as lipopolysac-
charide (LPS), teichoic acid, and surface lipoproteins, initiates
signal transduction through the NF-kB pathway [15]. Nuclear
translocation of NF-kB induces transcription of proinflammatory
cytokine genes essential to mounting a protective immune
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PLoS ONE | www.plosone.org 1 December 2007 | Issue 12 | e1318response and host defense. Different TLRs recognize distinct
classes of products synthesized by pathogens. For example, TLR4
is a receptor for LPS made by Gram-negative bacteria [16].
Consistent with this role, Arbour et al. [17] reported that amino
acid polymorphisms in the extracellular domain of TLR4
conferred altered responsiveness to inhaled LPS in humans.
Among the human TLR family members described to date,
TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, and TLR9 have been
implicated in the recognition of bacterial components [15].
Associations between TLR polymorphisms and susceptibility to
infectious agents have been reported [18–21]. However, the
conclusions that can be drawn from these studies are limited
because, in general, relatively few polymorphic sites have been
analyzed, small patient populations have been studied, and the
analyses have largely been confined to a single TLR gene.
TLRs have been reported to participate in the interaction of
pathogenic mycobacteria or their extracellular products with mice
and humans [22–34]. In particular, TLR2 in association with
TLR1 and TLR6, and TLR4 have been implicated as receptors
involved in the recognition of mycobacterial antigens and
activation of macrophages and dendritic cells (DCs) [28–35].
However, with few exceptions [36,37] there has been little
investigation in human patients of the role of TLR polymorphisms
in susceptibility to TB disease, reflecting a general lack of
understanding of this topic in human infections. Here we used
full-exon sequencing of TLR1, TLR2, TLR4, TLR6, and TLR10 to
test the hypothesis that TLR variants are significantly associated
with TB disease in humans.
RESULTS
Overview of Sequence Variation in the TLRs
Analysis of sequence variation in the coding regions of the five TLRs
in the 1,312 subjects from three ethnicities (African American,
European American, and Hispanic) identified 179 sequence variants
including 126 nonsynonymous polymorphisms (NSP, altering the
primary amino acid sequence) and 53 synonymous single nucleotide
polymorphisms (sSNPs, not resulting in an amino acid replacement)
(Figure 1B and Table S1). On average, each TLR had 25 NSPs
(range23–30 variants),and10sSNPs(range7–18).Thus,NSPswere
more abundant than sSNPs by a ratio of 2.5:1, a larger number than
is typically observed [38]. Most polymorphic sites were single
nucleotide polymorphisms (SNP; 174/179 variants), reflecting lower
thanaverageindelpolymorphism [38].Transition substitutionswere
more prevalent (130/174; 74.7%) than transversions (44/174;
25.3%) among these SNPs, a result consistent with other studies of
human DNA sequence variation [38]. Among the nonsynonymous
differences are included four rare deletions (1–5 bp in length), one
insertion (1-bp), and six nonsense variants (SNPs generating stop
codon) (Figure 1B and Table S1).
The proportion of amino acid residues that have a nonsynony-
mous polymorphism among the five target genes was very similar,
Figure 1. Schematic of the TLR proteins and sequence variants. (A) Schematic of human chromosome 4 showing location of TLR genes. (B)
Summary of variants identified in five TLR proteins. Shown are all variant sites that would be made by the TLR alleles identified in either the TB
patients or control subjects. Black, rare variant; red, variants that are common in all three ethnic groups analyzed. SG, signal peptide; TM,
transmembrane domain; TIR, Toll/IL-1 receptor domain; NSP, nonsynonymous polymorphisms (includes nonsynonymous single nucleotide
polymorphisms, nonsense mutations, and insertion and deletions). Numbers in parentheses denote amino acid residue positions.
doi:10.1371/journal.pone.0001318.g001
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784), 3.6% in TLR4 (30/839), 3.0% in TLR6 (24/796), and 3.1%
in TLR10 (25/811). Twenty-four of the NSPs were present in all
three ethnic groups, 22 in two ethnic groups, and 80 NSPs were
found in only one ethnic group, of which 53 NSPs presented only
once in one single individual (Figure 1B and Table S1). No
significant variation was observed among the three ethnic groups
in the frequency of occurrence of unique NSP per individual
(Table 1).
Four of the five TLRs we studied (TLR1, TLR2, TLR6, and
TLR10) are encoded by chromosome 4, and TLR6-TLR1-TLR10
comprises a gene cluster located within a 54-kb region of 4p14
(Figure 1A). TLR1 and TLR6 share 69% amino acid sequence
identity, TLR1 and TLR10 have 49% sequence identity, and
TLR6 and TLR10 have 47% sequence identity. In contrast,
TLR2 and TLR4 have much lower identity with each other and
other TLRs (range, 20%–30%). Alignment of TLR1, TLR6, and
TLR10 revealed that 20 of 73 (27.4%) NSPs were located at
amino acid sites conserved among these TLRs. This result may
indicate the functional importance of these rare or common NSPs.
There were 39 (53.4%) NSPs at homologous residues in more than
one TLR, a figure that exceeds the number expected by chance.
This result suggests that intergenic gene conversion may be
contributing to the variability seen in the TLR6-TLR1-TLR10
cluster.
Genotype Distribution
All polymorphic nucleotide sites present in the five TLRs were bi-
allelic. Treating each polymorphic site as a locus with two alleles,
we tested the hypothesis that the control subjects were taken from
a population in Hardy-Weinberg equilibrium. Of the 591 single
SNP tests for Hardy-Weinberg proportions, 17 had a P value less
that 0.05, a figure somewhat less than expected based on chance
alone. After correcting for multiple comparisons, there was no
significant deviation toward an excess or deficit of expected
heterozygosity (data not shown).
Rare NSPs in the TLR6-TLR1-TLR10 Gene Cluster Are
Significantly Overrepresented Among African
American TB Cases
We tested the hypothesis that TB patients and control subjects
differed significantly in the frequency of NSPs in the TLR6-TLR1-
TLR10 gene cluster. For this analysis, NSPs were divided into two
groups, designated as common (allele frequency$3%) and rare
(allele frequency,3%) NSPs. Inasmuch as polymorphisms were
present at different allelic frequencies in the three ethnic groups
studied, we defined each variant as rare or common based on its
frequency in each ethnic group (including cases and controls)
(Table 1). Due to the low allele frequencies of rare variants, and
findings reported for TLR4 in patients with meningococcal
infection [18], we pooled all rare NSPs within each TLR and
compared the frequencies of rare alleles between cases and
controls in each ethnic group (Table 2). Compared to control
subjects, African American tuberculosis cases had a significantly
increased frequency of rare NSPs in TLR1 (OR=3.32; P=0.002),
TLR6 (OR=1.85; P=0.040), and TLR10 (OR=1.76; P=0.009)
(Table 2). In contrast, European American cases had fewer rare
NSPs in these genes (ORs,1.00) compared to the controls, but
only showed statistical significance in TLR10 (OR=0.34;
P=0.006). In addition, TLR2 had significantly more rare NSPs
among Hispanic controls than the cases (OR=0.28; P,0.001).
There was no significant association found between rare NSPs in
TLR4 and TB disease across three ethnic groups, a result
consistent with a previous study of TLR4 SNPs [39]. Taken
together, the results support the idea that rare NSPs in several
TLRs are associated with altered susceptibility to TB disease. In no
case was there a significant association between the count of rare
synonymous SNPs and disease status.
Association of Common NSPs in the TLR6-TLR1-
TLR10 Gene Cluster with TB Disease
Nine NSPs were common in all three ethnic groups (Table S2).
TLR2 lacked common NSP variants. Genotypic frequencies for all
21 common NSP were compared between cases and controls
within corresponding ethnic groups. None of the three common
NSPs in TLR4 was associated with TB disease. In contrast, 15 of
the 18 common NSPs in the TLR6-TLR1-TLR10 gene cluster were
significantly associated with TB disease in one or more of the
ethnic groups (ORs from 1.63–6.77) (Table S2). This result
provided evidence that NSPs in the TLR6-TLR1-TLR10 gene
cluster contributed to human susceptibility to TB disease.
Two common TLR1 NSPs (N248S and S602I) were in linkage
disequilibrium and had reciprocal allele frequencies of minor and
major alleles between African Americans and European Ameri-
cans (Table S2). For example, the G and A alleles of N248S had
allele frequencies of 0.789 and 0.211 respectively, in African
Americans compared with 0.116 and 0.884, respectively in
European Americans. Alleles of both NSPs (248S and 602I) were
associated with TB disease in African American patients. N248
(common in European Americans) is a conserved amino acid site
in the extracellular domain of TLR1 and TLR6 (N253), and is a
putative glycosylation site. Replacement of the Asn residue with
Ser might result in altered glycosylation, potentially changing
TLR1 folding or function (e.g., PAMP recognition or signal
transduction). The S602I amino acid replacement alters the first
amino acid of the inferred intracellular domain of TLR1, and this
residue varies in TLR10 (L602) and TLR6 (I607). The odds ratios
for the tests of association of TLR1 N248S and S602I with TB in
African Americans were 1.63 and 2.50 (with tail P values of 0.009
and ,0.001 respectively), whereas the respective odds ratios in
European Americans were 0.20 and 0.49 (neither significant). The
two-locus analysis for these SNPs however yielded odds ratios for
the highest-risk genotype of 2.68 and 1.75 in African Americans
and European Americans, with corresponding P-values of ,0.001
and 0.007. The two-SNP haplotype contributed more to enhanced
susceptibility to TB disease than did the single SNPs in our sample.
These results are consistent with recent reports [21,31–34]
implicating TLR1 common variants such as S248N and S602I,
and rare variants H305L and P315L in altered innate immune
responses to lipopeptides and extracts of M. tuberculosis, and
differential susceptibility to leprosy.
Table 1. Distribution of common and rare nonsynonymous
variants of human TLR genes among different ethnic groups.
......................................................................
Ethnicities TLR1 TLR2 TLR4 TLR6 TLR10 Total
African American (n=533) 5/13* 0/17 2/16 5/13 5/14 17/73
European American (n=290) 3/7 0/7 2/8 1/7 6/6 12/35
Hispanic (n=489) 2/9 0/6 1/12 2/12 6/14 11/53
Total unique NSPs 24 23 30 24 25 126
*Number show the number of nonsynonymous common/rare variants in the
target genes based on a cutoff line of allelic frequency 0.03 for common and
rare variants in each single ethnicity. NSPs, nonsynonymous polymorphisms.
doi:10.1371/journal.pone.0001318.t001
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with TB
The genetic epidemiology data and the population genetic analysis
suggested that, as a population, rare TLR variants contribute to
human susceptibility to TB disease. If this is the case, it is reasonable
to expect that some of the rare TLR variants have altered function.
BecauseitwasnotpracticaltostudythefunctionalaspectsofallTLR
variants, we elected to focus our efforts on several TLR6 variants.
This TLR was chosen for analysis because it has been implicated in
MTB-host interaction in the mouse, and reporter assays were
available at the time when the nucleotide sequence data were
completed. It has previously been shown with Chinese hamster
ovary (CHO) cells that mouse TLR6 and TLR2 associate in a
ligand-independent manner to form a functional complex that
constitutively signals through the NF-kB pathway [40]. Similar
studies conducted with HEK 293 cells demonstrated NF-kB
activation as a consequence of the co-expression of human TLR2
and TLR6, and found that the cytoplasmic domains of these TLRs
were necessary for signaling [41].
Thus, we hypothesized that the TLR6 proteins resulting from
rare mutations that truncate TLR6, or mutations that alter the
Toll/interleukin-1 receptor (TIR) domain by a single amino acid,
would be defective in signal transduction. To test this hypothesis,
we generated TLR6 cDNA vectors expressing wild-type TLR6, a
dominant negative form of TLR6 (Pro680His), and 5 TLR6
variants. Of the 5 rare variants examined, 2 were truncated
receptors, the other two each had a single amino acid substitution
in the TIR domain. The TLR6 constructs were co-transfected with
ah u m a nTLR2 expression vector and an NF-kBr e p o r t e ri n t oH E K
293 cells and their ability to mediate NF-kB activation was assessed.
As predicted, the Pro680His dominant negative replacement
completely abolished NF-kB activation (Figure 2). The truncated
TLR6 variants (Leu251stop and codon 460/461-5 bp deletion) and
one of the TIR domain variants (Asn690Thr) were significantly
impaired in their ability to induce NF-kB activation compared to
wild-type TLR6 (Figure 2). The rare variant (Thr255Ile) character-
ized by a substitution in a region of the extracellular domain
containing a cluster of rare polymorphisms (Figure 1), also had a
significant decrease in NF-kB signaling (Figure 2).
TaqMan real-time RT-PCR analysis was used to verify that
there was no significant difference in the transcript level from the
various TLR6 constructs, indicating that the observed deficiencies
in signaling were not due to differences in the level of gene
expression from the constructs used (data not shown). Of note,
Thr756 is one of two amino acids in the entire TIR region that
varies between humans and chimpanzees, whereas the Asn690Thr
replacement is located in a region of the molecule that is well
conserved in human, chimpanzee, and mouse TLR6 (data not
shown). These observations suggested that an amino acid
replacement at Asn690 would have a more substantial detrimental
effect on NF-kB signaling than variation located at Thr756. This
prediction was borne out by the results of our functional studies
(Figure 2).
Table 2. Association between rare NSPs of TLR1, 2, 4, 6, 10 and TB disease
..................................................................................................................................................
African Americans European Americans Hispanics
Genes Cases n=339 Controls n=194 Cases n=180 Controls n=110 Cases n=375 Controls n=114
TLR1
Rare NSPs
* 12 5 4 4 9 5
Rare alleles
{ 39 7 9 9 41 13
OR, (P value)
{ 3.32 (0.002) 0.60 (0.284) 0.96 (0.892)
TLR2
Rare NSPs 15 5 5 3 6 4
Rare alleles 27 11 13 7 15 15
OR, (P value) 1.42 (0.331) 1.14 (0.783) 0.28 (,0.001)
TLR4
Rare NSPs 13 8 4 4 10 4
Rare alleles 42 33 4 5 30 13
OR, (P value) 0.71 (0.156) 0.48 (0.272) 0.69 (0.272)
TLR6
Rare NSPs 11 5 6 4 11 3
Rare alleles 47 15 12 8 19 8
OR, (P value) 1.85 (0.040) 0.91 (0.846) 0.71 (0.431)
TLR10
Rare NSPs 13 9 3 6 14 5
Rare alleles 90 31 10 17 46 9
OR, (P value) 1.76 (0.009) 0.34 (0.006) 1.59 (0.210)
*Number of nonsynonymous polymorphisms (NSPs) identified in each group.
{Number of alleles carrying rare nonsynonymous variants.
{Odds ratio (OR) and P value were calculated by comparing the numbers of alleles with rare nonsynonymous variants between the cases and controls in each ethnic
group.
doi:10.1371/journal.pone.0001318.t002
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PLoS ONE | www.plosone.org 4 December 2007 | Issue 12 | e1318Linkage between the TLR1-248S Variant and TB
Disease in Children
To further assess the finding from the adult case-control study that
TLR1 N248S and S602I were associated with TB disease
susceptibility, a separate family-based study was conducted to
evaluate the linkage between these two common variants and TB
disease. Among the 99 families studied, 64 families with both
parents available were informative for conventional transmission/
disequilibrium test (TDT) analysis by having at least one parent
who was heterozygous for N248S. A total of 99 transmissions of
the A (Asn) or G (Ser) allele of the TLR1 248 codon occurred from
heterozygous parents to affected children. The G allele was
transmitted 61 times compared to 38 times for the A allele, a
significant excess (P=0.021) (Table 3). A total of 53 families with
heterozygous parents of S602I were informative. We observed 83
transmissions of S602I T or G allele in these 53 families. The T
allele was transmitted 44 times (53.0%) compared with 39 times of
the G allele (47.0%) (P=0.875). The results provided additional
evidence supporting the association between N248S and increased
TB disease. The lack of linkage between S602I and TB disease in
this TDT study suggested that this variant might be less important
in pediatric than adult TB susceptibility.
DISCUSSION
TLR Variants and Susceptibility to TB Disease
Several lines of evidence suggest that TLR variants confer
enhanced susceptibility to TB disease in our patient sample. First,
there was a significant increase in the frequency of rare NSPs in
TB patients compared to the matched controls. Second, in the
case of TLR1, the TDT analysis revealed that the allele encoding
the TLR-248S variant was significantly overrepresented among
diseased children (P=0.021). Third, cell biology studies found that
several of the TLR6 variants were deficient in ability to mediate
signal transduction. A fourth line of evidence stems from the
population genetics analysis. By aligning human TLR6 coding
sequences with the Bos taurus homolog (NM_001001159.1), we find
that there were 167 nonsynonymous differences and 193
synonymous differences. These numbers vary somewhat depend-
ing on the human allele one uses, but the conclusion is robust to
this choice–the patient sample has an excess of nonsynonymous
variants (n=24) relative to the number of synonymous variants
(n=9) compared to the degree of divergence with cow (McDo-
nald–Kreitman test, X
2=8.39, P,0.004). The pattern of poly-
morphism in TLR6 in TB patients deviated significantly from
neutrality, and the major cause was an excess of rare mutations
that would alter the primary amino acid sequence of TLR6.
Inasmuch as singleton mutations occurred in significant excess in
TB patients, the increase in susceptibility to TB disease associated
with these polymorphisms must be substantial. In this regard, we
note that before the introduction of widespread anti-MTB drug
therapy in the 1950’s, the death rate from TB was very high.
Hence, the data are broadly consistent with a process whereby
variants that reduce the ability to fight infections enter the
population by mutation, but have been maintained at a low
frequency by the action of natural selection. This process leads to
an excess of rare nonsynonymous polymorphism in the human
population compared to the number of nonsynonymous fixations
between humans and chimpanzees.
Haplotype analysis can be more powerful than SNP analysis for
providing insight into the genetic basis of complex traits [42], and
provides a fifth line of evidence for the role of TLR polymorphism
in TB susceptibility. We found that both rare SNPs and rare
haplotypes of TLR6 also were significantly overrepresented among
the TB patients relative to the matched control population. The
rare haplotypes present in TB patients do not cluster closely
together in the phylogenetic network of TLR6 (Table S3 and
Figure S1). Simulations of the neutral coalescent [43], with each
sample of size 1,312 having 31 segregating sites (like TLR6) were
performed to ask how often a random partition into 894 cases and
418 controls would produce a more extreme association with rare
alleles in the case group by chance. This test found that only 3 out
of 1000 samples had more than the observed number of singletons
present in the group of cases than was observed in TLR6. The data
appear to be consistent with the rare haplotypes being derived
independently (and by their rarity, we infer recently) from multiple
common haplotypes by single genetic events such as nucleotide
substitution or deletion of a short segment of DNA. Insofar as
TLR6 is concerned, this means that TB disease is not associated
with a single unique mutation, rather, many independent
mutations are associated with enhanced disease susceptibility.
Our findings may bear on a report in the literature suggesting that
African Americans may have an enhanced susceptibility to TB
disease [44]. We found significant association between common and
rare NSPs and increased susceptibility to TB disease in African
Americans. The TDT analysis also revealed an association between
TLR1 and TB susceptibility. However, these findings were not
Table 3. TDT analysis of N248S and S602I in families with
pediatric TB cases
......................................................................
Transmitted Non-Transmitted x
2 P
G allele of N248S 61 (61.6%) 38 (38.4%) 5.34 0.021
T allele of S602I 44 (53.0%) 39 (47.0%) 0.30 0.875
doi:10.1371/journal.pone.0001318.t003
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Figure 2. Altered NF-kB signal transduction by rare variants of TLR6.
HEK 293 cells were transiently co-transfected with TLR2 and the
indicated TLR6 variant expression plasmids, NF-kB reporter (firefly
luciferase), and b-actin Renilla luciferase plasmids. NF-kB activation in
transfected cells was measured 24 hrs post transfection. The data
shown are the mean 6 SD from 4 independent experiments expressed
as the percent relative firefly luciferase activity (RLU) (normalized to
Renilla luciferase activity) induced in cells co-expressing TLR2 and WT
TLR6.*P,0.01; ** P,0.001 compared to TLR6 WT NF-kB activity.
doi:10.1371/journal.pone.0001318.g002
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populations. It is reasonable to consider what factors may account
for the differences between populations. On average, these three
populations have quite different recent ancestral histories, which
means that they have undoubtedly encountered distinct selective
forces, including but not limited to lethal infectious agents such as M.
tuberculosis. In this regard, we note that Ferwerda et al. [45] recently
have hypothesized that certain nonsynonymous amino acid changes
polymorphisms in TLR4 rose to high frequency in sub-Saharan
Africa because they protect against malaria.
Simply because of their rarity, individual rare variants are not
shared across populations, adding to the apparent heterogeneity
across population samples in TLR associations. It is very possible
that some rare variants increase and some decrease susceptibility to
TB. Given that the long-term effective population size of African
Americans is larger than the other two populations we studied, one
would expect more rare variants to occur in that population.
Although several environmental factors are likely operative, and
many genes contribute to TB susceptibility, a larger pool of rare
variants (in either TLRs or other proteins) could be a factor
contributing to an enhanced susceptibility to TB. We note that
different selection pressures may alsoaccount for thereciprocal allele
frequencies at the common variant sites (for example, TLR1-248
and TLR1-602) observed in the African American and European
American populations. We also note that several of the amino acid
polymorphisms we identified in TLR1 and TLR2 map to regions of
these proteins that interact with each other and with lipopeptide, as
recently revealed by crystal structure analysis [46].
Detrimentally Altered Signal-Transduction by Rare
Variants of TLR6 and TB Disease Susceptibility
Whether an individual develops TB disease or remains asymptom-
aticafterexposuretothe bacteriumdependson theabilityofthe host
toeffectivelykillMTBorsufficientlycontrolitsreplication.Members
of the TLR family of proteins recognize ligands derived from a
variety of pathogens and trigger crucial steps in the protective
immune response against infectious agents. TLR6 forms a
heterodimeric complex with TLR2 to activate macrophages [40],
a critical step in defense against MTB. Bulut et al. [47] reported that
the dominant-negative mutant of mouse TLR6 (Pro691His)
inhibited the ability of transfected cells to respond to soluble
tuberculosis factor. Hence, it is reasonable to conclude that some of
the rare TLR6 variants we identified in the TB patients have altered
function.Indeed,the resultsofourcellbiologystudies,whichfocused
on the formation of a functional TLR2/TLR6 signaling complex,
confirmed this idea. Under a current model of TLR function [15],
the proinflammatory signal-transduction cascade that protects the
host from disease caused by MTB may be detrimentally altered in
individuals with rare TLR6 variants, thereby leading to enhanced
likelihood of clinical disease. Studies are underway to examine this
issue in the context of primary cells obtained from patients and
controls with known TLR6 genotypes.
Rare Variants of Proteins Involved in Human Innate
Immune Function and Infectious Disease
Susceptibility
It is generally accepted that human susceptibility to TB disease is a
complex genetic trait [4,5]. Substantial controversy exists in human
medical genetics regarding the contribution of common and rare
mutations to susceptibility to complex diseases [48,49]. One school
of thought favors the idea that common genetic diseases are
associated with polymorphisms that are present in relatively high
frequency in a population (common disease/common variant
model). Another school of thought argues that rare mutations play
a much more important role in susceptibility to common diseases
than usually assumed, and interest in this area is accelerating [50–
52]. The results of our study support both arguments. While we do
find common variants that display significant association with TB
susceptibility, we also present evidence that rare variants of proteins
that detrimentally alter innate host defense are important
contributors to the outcome of the interaction between a bacterial
pathogen and the infected individual. This theme is echoed by the
finding that a large array of distinct rare variants of the IL-12
receptor b1 result in enhanced susceptibility to infections caused by
bacteria such as Salmonella spp., M. tuberculosis BCG, and
environmental mycobacteria [53–55]. Moreover, we note that
well over 200 otherwise rare mutations can cause X-linked chronic
granulomatous disease [56], an abnormality characterized by
altered ability of polymorphonuclear leukocytes to kill several
bacterial and fungal pathogens. Similarly, Picard et al. [57] recently
reported the occurrence of rare mutations in IRAK-4 that confer
susceptibility to pyogenic bacterial infections.
Thus far, human TB susceptibility studies have been conducted
largely by association studies that examine the effect of common
mutations in patients and controls [4,5]. One important practical
consequence of the involvement of many distinct rare variants in
host defense is that it likely will be necessary to completely
sequence candidate susceptibility genes in large samples of affected
individuals and control subjects to identify disease association.
In summary, by discovering a link between TLR variants, altered
TLR signal transduction, and enhanced susceptibility to TB disease,
our findings provide strong impetus to analyze the relationship
between nucleotide sequence variation in other human candidate
genes, and susceptibility to infectious agents. Our study wasdesigned
toinvestigate the associationofTLRvariants withTBdisease in only
one geographic area that was purposely defined narrowly. Our
findings may not be generally applicable to all TB patients. Indeed,
there is substantial variance in the results of TB susceptibility studies
reported in the literature for mice and humans [4,5,58]. In the case
of humans, this variance may be caused by differences in ethnicity,
environmental factors such as nutrition, and exposure to non-
tuberculous mycobacteria. Another variable that may, in principle,
influence host-pathogen interaction is the relative frequency of
distinct clones of MTB circulating in the human population under
study. Although strains of MTB are, on average, relatively closely
related in overall chromosomal character, many strain-to-strain
genetic differences have been described, and the frequency of
occurrence of distinct clones differs geographically [59–62]. In
addition,evidence is accumulating that strains can differsignificantly
in virulence [63]. The possibility that different host genotypes have
differential susceptibility across different MTB strains remains to be
tested. It is a formal possibility that the mechanisms used by MTB
strains to overcome host immunity differ in a strain-dependent
fashion, or differ depending on human genotype/strain genotype
combination. Clearly, studies analogous to the one we report here
need to be conducted in human populations that differ in ethnicity
and age from the one we investigated. It is also reasonable to
speculate that rare TLR variants influence human susceptibility to
disease caused by other infectious agents.
MATERIALS AND METHODS
Population-Based Adult Case-Control Study
This study was based on analysis of 1,312 HIV-seronegative adults
living in Houston, Texas, enrolled in a population-based study of
TB [7,64]. Patients (n=894) with TB disease included 339 African
TLR Genetics and Tuberculosis
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monary TB, 15.6%), 180 European Americans (mean6SD,
51.7613.6; male, 75.0%; extrapulmonary TB, 11.1%), and 375
Hispanics (mean6SD, 42.3617.2; male, 63.5%; extrapulmonary
TB, 14.7%). All patients were identified by either MTB culture
positivity (92.8%) or clinical improvement (7.2%) in response to
antimycobacterial treatment without a history of immunosuppres-
sive condition. Extra-pulmonary TB was defined as involvement of
an extrathoracic site, or the thoracic pleura or lymph nodes
according to the official statement of the American Thoracic
Society and the Centers for the Disease Control and Prevention
(CDC). Patients with both pulmonary and extra-pulmonary TB
were classified as extra-pulmonary. None of the patients were
known to be genetically related.
The control sample (n=418) consisted of 194 African Americans
(mean6SD, 45.5610.6; male, 75.8%), 110 European Americans
(mean age6SD, 50.0610.0; male, 67.3%) and 114 Hispanics
(mean age6SD, 43.4611.0; male, 58.8%) without a history of TB
disease, autoimmune diseases, and other infectious diseases. These
individuals either lived in the same neighborhood as a TB patient
or were health care workers. All control subjects were followed for
at least 6 months to confirm their clinical status. In this study,
ethnicity was determined by self-identification. European Ameri-
cans were defined as non-Hispanic, white individuals. Written
informed consent was obtained from all study participants for the
studies performed herein. The study was approved by the
Institutional Review Board at Baylor College of Medicine.
Cut-off lines used for rare and common polymorphisms are
usually 1% to 5% depending on the study. We used 3% as a cut-
off value because the sample sizes in our adult case-control study
ranged from 110 to 375 in different ethnic groups of cases and
controls. If a SNP had an allele frequency of 3% in one ethnic
group, it will have at least 6.6 alleles in the smallest group having
110 individuals (e.g. European American controls). This is
statistically feasible for a 262 Chi-square test.
Transmission/Disequilibrium Test (TDT) within the
Families of Children with TB
To avoid potential bias in the adult case-control study caused by
population substructures or control selection, a separate family-
based association study using TDT was conducted to provide
additional support for the detected TLR1 variant associations.
Ninety-nine nuclear families consisting of one child with TB and two
biological parents from the greater Houston area were studied.
Sequencing of TLR Genes
Genomic DNA was prepared from peripheral blood leukocytes by
standard phenol-chloroform extraction methods. Full-coding
region sequencing was conducted on all five TLR genes (TLR1,
TLR2, TLR4, TLR6, and TLR10) in the 1,312 subjects. PCR
products used for sequencing were obtained by amplifying
genomic DNA with the primers shown in Table S4. DNA
sequencing was conducted with an ABI 3730 instrument. The
software used for initial data analysis was Sequencher (Gene
Codes, Ann Arbor, MI). All raw data were assembled and
analyzed by two individuals independently and blinded to the
analyses performed by the other. The data were compared, and
the few discrepancies were resolved. This procedure, although
tedious, resulted in a data set of unusually high quality.
Statistical Analysis of the Adult Subject Data
Within each ethnic grouping, the 179 SNP genotypes were
examined for hidden population subdivision using the program
STRUCTURE 2.2 [65]. Seeing no evidence for latent structure,
HardyWeinbergtestswereperformedforeachSNPthatpresented3
genotypic classes. The homogeneity of frequencies of genotypes
between the cases and controls in each ethnic group were tested by
using a Chi-squaretestfortwo-by-two andtwo-by-three contingency
tableswithSAS(version8.0,SASInstitute;Cary,NC).P-valueswere
corrected for multiple comparisons by the formula (Pcorr=1–[1–P]
n,
with P being the uncorrected P value, and n the number of
comparisons). A Pcorr less than 0.05 was considered to be statistically
significant.Thesignificanttestsreportedherewerealsosignificantby
standard Bonferroni correction.
Plasmid Constructs and Site-Directed Mutagenesis
The reference allele and the most common allele of human TLR6,
haplotype h2 (Figure S1 and Table S3), were amplified from
genomic DNA and cloned into pCR-XL-TOPO (Invitrogen,
Carlsbad, CA). Rare allelic variants of TLR6 and the allele of
TLR6 encoding a dominant-negative form (Pro680His) of the
receptor were made using the QuickChange Multi Site-Directed
Mutagenesis system (Stratagene, La Jolla, CA). The analogous
dominant negative mutation in mouse TLR6 (Pro691His) was
reported and characterized previously [41]. SpeI restriction
fragments made from the pCR-TOPO-XL-TLR6 clones contain-
ing the TLR6 allelic variants were subcloned into the pUNO-
hTLR6 cDNA expression vector (InvivoGen, San Diego, CA).
The TLR6 allelic variant, h19 (Figure S1), characterized by a 5 bp
deletion at codon 460 and 461, had additional common
polymorphisms of which one occurred outside of the SpeI sites.
Thus, the TLR6 gene for the 5 bp deletion variant was amplified
from genomic DNA and cloned into the AgeI and NheI sites of
pUNO-hTLR6. All constructs were verified by sequencing of the
complete TLR6 with an ABI PRISM 3700 DNA Analyzer
(Applied Biosystems, Foster City, CA). The b-actin-Renilla
luciferase construct used as a transfection control was generously
provided by C.B. Wilson and A.M. Hajjar, University of
Washington. The NF-kB reporter plasmid, ELAM-1-firefly
luciferase, and the human TLR2 cDNA expression construct,
gD.TLR2, have been described previously [31,33].
Cell Culture, Transfections, and Dual Luciferase
Reporter Assays
The human embryonic kidney (HEK) 293 cell line (CRL-1573)
was purchased from the American Type Culture Collection
(Manassas, VA) and grown at 37uCi n5 %C O 2 in DMEM
medium supplemented with 10 mM HEPES, 100 IU penicillin,
100 mg streptomycin/ml, and 10% fetal bovine serum (Invitrogen,
Carlsbad, CA). HEK 293 cells were seeded into 24-well plates
(1610
5 cells/well) the day before transfection. Cells were transiently
transfected with 0.3 mg of the specified TLR6 expression construct
and 0.006 mg of plasmid gD.TLR2, 0.091 mgo fN F - kB reporter,and
0.003 mgo fb-actin-Renilla luciferase plasmid. Transfections were
performed using FuGene 6 transfection reagent (Roche, Indianapo-
lis, IN) as recommended by the manufacturer. Twenty-four hours
posttransfection, celllysateswerepreparedand luciferaseactivity for
each reporter construct was determined using the Dual-Luciferase
Reporter assay system (Promega, Madison, WI) following the
manufacturer’s specifications.
SUPPORTING INFORMATION
Figure S1 Haplotype analysis of TLR6 variants. Thirty-two
haplotypes were identified or inferred based on the segregation
sites in the coding region of TLR6. The reference sequence from
TLR Genetics and Tuberculosis
PLoS ONE | www.plosone.org 7 December 2007 | Issue 12 | e1318the database (GenBank accession no. AB020807) was designated
as h0. Six of 32 haplotypes were characterized by the presence of
only 1 mutation, whereas the other 27 haplotypes were
differentiated by at lease 2 mutations (Table S3). The haplotypes
tend to cluster in two major clades, h0 and h2. The chimpanzee
lineage was located between the two major clades, suggesting that
h0 and h2 are probably quite ancient. Three cycles are present in
the haplotype network (h2-h7-h10-h2; h2-h1-h6-h8-h2; h2-h22-
chimp-h2), suggesting that intragenic recombination or repeated
mutation occurred in the evolutionary history of TLR6.
Found at: doi:10.1371/journal.pone.0001318.s001 (1.17 MB TIF)
Table S1 Genetic variants in human TLR1, 2, 4, 6, 10 genes
Found at: doi:10.1371/journal.pone.0001318.s002 (0.10 MB
PDF)
Table S2 Associations between common nonsynonymous vari-
ants of TLR1, 4, 6, 10 genes with TB and Extrapulmonary TB
(EPTB) disease
Found at: doi:10.1371/journal.pone.0001318.s003 (0.21 MB
DOC)
Table S3 Haplotype analysis of TLR6 genetic variants
Found at: doi:10.1371/journal.pone.0001318.s004 (0.04 MB
PDF)
Table S4 Oligonucleotide primers used to amplify and sequence
TLR1, 2, 4, 6, and 10
Found at: doi:10.1371/journal.pone.0001318.s005 (0.06 MB
PDF)
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